KEEPING UP WITH THE KOLs: Colorectal cancer screening
This article was originally published in Clinica
In the second instalment of Clinica’s KOL interview series, Dr Guy Chung-Faye, consultant gastroenterologist and head of screening at King’s College Hospital London, discusses the need for more sensitive methods to detect early-stage colorectal cancer, how he sees the recently CE-marked Cologuard test by Exact Sciences fitting into the UK’s colorectal cancer screening program and what other opportunities for improvement exist in this space
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.